Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000135

EVP, Chief Reg. & Quality Off. sold 530 shares at $475.34 ($251,930)

  • EVP, Chief Reg. & Quality Off. gave up 4,962 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tatsis Ourania · EVP, Chief Reg. & Quality Off.

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-26 Shares withheld for taxes : show line 1 in the form 10b5-1 −4,962 $479.61 $2,379,825 59,069 D
2025-02-27 Sale : show line 2 in the form 10b5-1 −530 $475.34 $251,930 58,539 D
Open-market sales · 530 sh · avg $475.34 · $251,930
Loading xslF345X05/wk-form4_1740779311.xml…